Type 1 diabetes patients

Clinical trials for Type 1 diabetes patients explained in plain language.

Never miss a new study

Get alerted when new Type 1 diabetes patients trials appear

Sign up with your email to follow new studies for Type 1 diabetes patients, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New drug aims to control type 1 diabetes early

Disease control Recruiting now

This study tests a new drug, CNP-103, in people aged 12 to 35 who were diagnosed with stage 3 type 1 diabetes within the last 6 months. The goal is to see if the drug is safe and can help control the disease. Participants will receive either the drug or a placebo, and researchers…

Matched conditions: TYPE 1 DIABETES PATIENTS

Phase 1/2 • Sponsor: COUR Pharmaceutical Development Company, Inc. • Aim: Disease control

Last updated Sep 13, 2026 00:00 UTC

Type 1 diabetes patients

Get alerted when new Type 1 diabetes patients trials appear

New drug aims to control type 1 diabetes early